ISG to Study AI Service Providers in Life Sciences
Upcoming ISG Provider Lens® report will evaluate providers helping life sciences enterprises adopt AI for drug discovery, clinical development and commercial operations
Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm, has launched a research study examining providers that help enterprises improve research productivity, optimize development pipelines and enhance patient outcomes through AI.
The study results will be published in a comprehensive ISG Provider Lens® report, called AI Services in Life Sciences 2026 — Strategic Capabilities, scheduled to be released in November 2026. The report will cover companies offering services related to AI strategy and transformation, along with AI platform engineering, deployment and operationalization across the life sciences industry.
Enterprise buyers will be able to use the report’s insights to evaluate their current vendor relationships, identify potential new engagements and compare available offerings. ISG advisors will use the research to guide clients through increasingly complex transformation and platform investment decisions.
